PROGRESSIVE PULMONARY FIBROSIS
Clinical trials for PROGRESSIVE PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung scarring: phase 3 trial launches
Disease control OngoingThis study tests an experimental drug (BMS-986278) in about 1057 adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. The goal is to see if the drug can slow disease progression and is safe. Participants will receive either the drug or a …
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 05:38 UTC
-
Inhaled drug shows promise for Long-Term lung scarring control
Disease control ENROLLING_BY_INVITATIONThis study is for people with lung scarring (idiopathic pulmonary fibrosis or progressive pulmonary fibrosis) who have already been in a related study. It tests the long-term safety of an inhaled medication called treprostinil. The goal is to see if the drug is safe and tolerable…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Lung disease study probes hidden environmental triggers
Knowledge-focused OngoingThis study tracks 1000 adults with interstitial lung disease to see how often work or home exposures (like chemicals or pollution) play a role. Researchers use a standard questionnaire across multiple centers. The goal is to better understand causes, not to test a new treatment.
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated May 26, 2026 05:42 UTC
-
New MRI technique could reveal how lung scarring drugs really work
Knowledge-focused OngoingThis study at Duke University is testing whether a special type of MRI (using xenon gas) can track changes in the lungs of people with interstitial lung disease (ILD) who are starting anti-fibrotic therapy. About 60 adults with progressive lung scarring will have MRI scans before…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Italian study tracks genetic clues in lung disease
Knowledge-focused OngoingThis study follows 250 adults with inherited forms of pulmonary fibrosis to see how their genes influence the speed of lung decline. Participants undergo regular breathing tests and genetic analysis, but no new treatments are tested. The goal is to better understand why some peop…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC